Brahms
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Brahms sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Brahms: 5 sponsored US clinical trials, none currently recruiting.
Brahms sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Small Intestinal Neoplasms, with 1 trials.
Upper-quartile sponsor footprint
Brahms sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Chromogranin A as Blood Marker in Cancer Patients
NCT03817866
Procalcitonin Monitoring Sepsis Study
NCT01523717
Investigation of the Biomarker Copeptin in Patients With Acute Myocardial Infarction
NCT00952744
Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection
NCT00407147
Biomarkers in Acute Heart Failure
NCT00537628
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
How the Brahms archive is shaped
5 indexed studies, none listed as recruiting (0% open); 4 completed (80%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Small Intestinal Neoplasms (1 trial), 4 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Brahms: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Brahms sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Brahms page
5 registered trials is a research-attention snapshot, not an endorsement of Brahms or any single study.
- None of Brahms's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Small Intestinal Neoplasms is the condition Brahms studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Small Intestinal Neoplasms trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Brahms pipeline card: 5 registered trials from official public datasets.Report a data error.